Matches in Wikidata for { <http://www.wikidata.org/entity/Q71703281> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q71703281 description "artículu científicu espublizáu en xunetu de 1996" @default.
- Q71703281 description "im Juli 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71703281 description "scientific article published on 01 July 1996" @default.
- Q71703281 description "wetenschappelijk artikel" @default.
- Q71703281 description "наукова стаття, опублікована в липні 1996" @default.
- Q71703281 name "Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer" @default.
- Q71703281 name "Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer" @default.
- Q71703281 type Item @default.
- Q71703281 label "Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer" @default.
- Q71703281 label "Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer" @default.
- Q71703281 prefLabel "Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer" @default.
- Q71703281 prefLabel "Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer" @default.
- Q71703281 P1433 Q71703281-C2561298-FEAC-4A46-8B59-12A43471E717 @default.
- Q71703281 P1476 Q71703281-FE6F7A57-5EFC-468C-A0DF-7097D422F30E @default.
- Q71703281 P2093 Q71703281-1BE198FD-ACB5-4A74-9A76-C62E28891AF9 @default.
- Q71703281 P2093 Q71703281-1C0630BC-56A1-4906-AF83-1FA2FEA438A0 @default.
- Q71703281 P2093 Q71703281-516FAE7A-27F8-48A1-86E0-C2133DD14AC0 @default.
- Q71703281 P2093 Q71703281-56A57FD4-C89D-420B-B3CF-6CCE9CBE369E @default.
- Q71703281 P2093 Q71703281-73144343-A46B-47C9-9257-2728DD85FA87 @default.
- Q71703281 P2093 Q71703281-8E551EC3-33EF-4E84-B353-B5ED7F6F1A75 @default.
- Q71703281 P2860 Q71703281-30C4B640-9FE2-451A-8453-528B7AB9C837 @default.
- Q71703281 P2860 Q71703281-C8DE73E9-7031-43F5-B051-75834264B4B8 @default.
- Q71703281 P2860 Q71703281-F2B2184B-7600-4D9C-A136-8CF36309D089 @default.
- Q71703281 P304 Q71703281-038049E3-172D-4365-895F-1EE8875FC8E2 @default.
- Q71703281 P31 Q71703281-1A002341-51AA-44D3-9C4C-6B9708EBBB8B @default.
- Q71703281 P356 Q71703281-EF00CB33-18ED-46B4-9501-CB76AE29C3C2 @default.
- Q71703281 P433 Q71703281-34F17746-A517-411E-9749-52D74A92E15E @default.
- Q71703281 P478 Q71703281-C3616363-1826-47F8-814D-5142A3E97043 @default.
- Q71703281 P577 Q71703281-BD98790B-CCD6-4167-822B-BFA2907F50EB @default.
- Q71703281 P698 Q71703281-0E615AA9-3F31-4583-BA29-18981497D784 @default.
- Q71703281 P921 Q71703281-779D9359-4DF6-4DCF-8079-0B57975D3388 @default.
- Q71703281 P921 Q71703281-B45E376D-187F-41FF-8D5E-73F53D4DE42F @default.
- Q71703281 P356 S0149-2918(96)80215-3 @default.
- Q71703281 P698 8879893 @default.
- Q71703281 P1433 Q15716601 @default.
- Q71703281 P1476 "Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer" @default.
- Q71703281 P2093 "B Stein" @default.
- Q71703281 P2093 "M C Gittleman" @default.
- Q71703281 P2093 "P B Hudson" @default.
- Q71703281 P2093 "R C Bruskewitz" @default.
- Q71703281 P2093 "R Sharifi" @default.
- Q71703281 P2093 "S D Graham" @default.
- Q71703281 P2860 Q40398462 @default.
- Q71703281 P2860 Q67266433 @default.
- Q71703281 P2860 Q88230168 @default.
- Q71703281 P304 "647-657" @default.
- Q71703281 P31 Q13442814 @default.
- Q71703281 P356 "10.1016/S0149-2918(96)80215-3" @default.
- Q71703281 P433 "4" @default.
- Q71703281 P478 "18" @default.
- Q71703281 P577 "1996-07-01T00:00:00Z" @default.
- Q71703281 P698 "8879893" @default.
- Q71703281 P921 Q181257 @default.
- Q71703281 P921 Q907160 @default.